Benzimidazole derivative and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9212169
APP PUB NO 20150011600A1
SERIAL NO

14382048

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention aims to provide a compound capable of inhibiting PCA-1 that can be a target for a novel treatment method of various diseases, and pharmaceutical use of the compound. A compound represented by the formula (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OSAKA UNIVERSITYSUITA-SHI OSAKA 565-0871
KAGOSHIMA UNIVERSITY21-24 KORIMOTO 1-CHOME KAGOSHIMA-SHI KAGOSHIMA 890-8580

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Aoki, Shunji Kobe, JP 75 318
Furukawa, Tatsuhiko Kagoshima, JP 12 58
Mizuno, Hiroaki Kobe, JP 48 261
Tanaka, Akito Kobe, JP 38 262
Tokoro, Miyuki Kobe, JP 1 0
Tsujikawa, Kazutake Suita, JP 12 68

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 15, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00